Geovanny Vicente – Página 539

The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis

LONDON, Aug. 4, 2020 /PRNewswire/ — Roots Analysis has announced the addition of «Live Biotherapeutic Products and Microbiome Contract Manufacturing Market, 2020-2030: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030« report to its list of…

Manufacturing live biotherapeutic products is both technically challenging and financially demanding; as a result, innovator firms are becoming increasingly reliant on contract service providers to access specialized facilities and optimize overall costs.

To order this 300+ page report, which features 140+ figures and 125+ tables, please visit this link

Key Market Insights

Over 25 players claim to provide microbiome-based live biotherapeutics contract manufacturing

More than 80% of the companies engaged in this domain are mid-sized and large firms; examples of firms established in 2019 include Arranta Bio and BacThera (a Lonza and Chr. Hansen joint venture). Further, nearly 50% of the CMOs have established the necessary expertise for handling both anaerobic and aerobic strains.

35+ manufacturing facilities focused on live biotherapeutics have been established worldwide

Majority (~55%) of the manufacturing facilities are located in Europe, followed by North America. Prominent manufacturing hubs in the Europe include (in decreasing order of number of manufacturing facilities) the UK, France, the Netherlands, Italy, Germany, Switzerland, and Sweden.

Approximately 88% of the total installed capacity is dedicated to commercial scale manufacturing

Whereas, rest (~10%) of the capacity is being used for preclinical / clinical scale manufacturing of microbiome products. In addition, over 60% of the total current global, installed manufacturing capacity is installed in Europe.

Over 170 registered clinical trials involved the use of microbiome-based live biotherapeutics

Majority of these studies are being conducted at various hospitals / centers across the US. Examples of leading non-industry players include (in decreasing order of number of trials) University of California, National Institute of Allergy and Infectious Diseases, Radboud University, and The University of Texas Health Science Center.

The global clinical demand for microbiome-based live biotherapeutic products is anticipated to grow at a CAGR of 23%, between 2020 and 2030

By 2030, over 31,000 patients are estimated to be enrolled in the clinical trials involving the use of microbiome-based live biotherapeutics. Industry players are anticipated to contribute majority (over 60%) of the demand in the short-term as well as long-term.

Several big pharma players are actively engaged in the microbiome live biotherapeutics domain

In fact, leading pharmaceutical companies have partnered with smaller business entities to develop manufacturing capabilities related to microbiome-based therapies / diagnostics. Examples of such small ventures with players with in-house capability include (in alphabetical order) Assembly Biosciences, Enterome Bioscience, Finch Therapeutics and NuBiyota.

By 2030, North America and Europe are anticipated to capture over 85% of the market opportunity

In terms of type of product manufactured, APIs currently represent the highest share (58%); this trend is unlikely to change in the foreseen future.

To request a sample copy / brochure of this report, please visit this link

Key Questions Answered

Who are the leading CMOs offering microbiome contract manufacturing services, across the world?
What are the key challenges faced by microbiome contract manufacturers?
Who are the most likely partners (microbiome-based live biotherapeutic drug developers) for microbiome contract manufacturers?
What is the annual clinical demand for microbiome-based live biotherapeutic products?
What is the current, installed contract manufacturing capacity for live biotherapeutics?
What are the key factors influencing the make (manufacture in-house) versus buy (outsource) decision in this field?
What are the various initiatives undertaken by big pharma players in this domain?
What percentage of live biotherapeutics manufacturing operations are outsourced to service providers?
How is the current and future market opportunity likely to be distributed across key market segments?
What are the anticipated future trends related to live biotherapeutics manufacturing?

The USD 300 million (by 2030) financial opportunity within the microbiome contract manufacturing market has been analysed across the following segments:

Type of Product Manufactured
Active Pharmaceutical Ingredients (APIs)
Finish Drug Formulations (FDFs)
Type of Type of Formulation
Solid Formulations
Oral Liquids
Injectables
Others
Scale of Operation
Clinical
Commercial
Company Size
Small-sized
Mid-sized
Large
Key Geographical Regions
North America
Europe
Asia-Pacific and Rest of the World

The report features inputs from eminent industry stakeholders, according to whom the microbiome therapeutics contract manufacturing services market is likely to witness substantial growth in the foreseen future. The report includes detailed transcripts of discussions held with the following experts:

Veronika Oudova (Co-founder and Chief Executive Officer, S-Biomedic)
Gaurav Kaushik (Chief Executive Officer and Managing Director, Meteoric Biopharmaceuticals)
Assaf Oron (Chief Business Officer, BiomX)
Alexander Segal (Vice President, Business Development, Universal Stabilization Technologies)
Debbie Pinkston (Vice President, Sales and Business Development, List Biological Laboratories)
JP Benya (Vice President, Business Development, Assembly Biosciences)
Rob van Dijk (Business Development Manager, Wacker Biotech)
Alexander Lin (Associate General Manager, Chung Mei Pharmaceutical)

The research covers detailed profiles brief profiles of several companies (including those listed below); each profile features an overview of the company, its financial information (if available), microbiome-related service portfolio, facilities dedicated to microbiome manufacturing, and an informed future outlook.

Biose®
BJP Laboratories
Capsugel (acquired by Lonza)
Cerbios-Pharma
Cobra Biologics (acquired Cognate Bioservices)
Inpac Probiotics
Paragon Bioservices (a unit of Catalent Biologics)
UAS Labs

For additional details, please visit https://www.rootsanalysis.com/reports/view_document/microbiome-contract-manufacturing/306.html or email sales@rootsanalysis.com

You may also be interested in the following titles:

Contact:
Gaurav Chaudhary
+1-(415)-800-3415
+44-(122)-391-1091
Gaurav.Chaudhary@rootsanalysis.com

View original content:http://www.prnewswire.com/news-releases/the-contract-manufacturing-market-for-live-biotherapeutics-and-microbiome-products-is-estimated-to-be-worth-usd-300-million-by-2030-growing-at-a-cagr-of-46-claims-roots-analysis-301105752.html

SOURCE Roots Analysis

HOLA! USA en Español lanza su primera portada digital con una entrevista exclusiva al artista venezolano ganador del Latin Grammy, Nacho Mendoza

NUEVA YORK, 4 de agosto de 2020 /PRNewswire-HISPANIC PR WIRE/ — HOLA! USA anuncia su primera portada digital para la edición En Español. Esta iniciativa es parte del proceso de adaptación a las generaciones digitales, al tiempo que la marca conserva su tradición, de más de 75 años, de publicar historias exclusivas.

«Nuestra audiencia es predominantemente móvil y lleva un tiempo siendo 100% digital, por lo que la publicación de portadas digitales es un paso no solo lógico, sino estratégico en cuando nuestra visión editorial. Nuestro objetivo es ofrecer a nuestros lectores contenido que disfruten consumiendolo en sus móviles. Al mismo tiempo, queremos dar a latinos influyentes una plataforma para comunicarse directamente con sus fans y comunidades Latinx,» dijo Nagidmy Marquez, Directora Editorial Ejecutiva de HOLA! USA

«Tenemos un legado y una pasión por compartir historias de interés humano. El lanzamiento de la primera, de muchas, portadas digitales En Español es una demostración de la confianza que las celebridades sienten por la marca HOLA!. Nos complace anunciar que el debut de la primera portada digital es con el ganador del Latin Grammy, el cantante venezolano, Nacho Mendoza. Es una entrevista exclusiva donde Nacho se sincera con sus fans y nos habla de su nueva etapa tanto profesional como personal,» continúa Nagidmy.

HOLA! USA es la primera marca Latinx enfocada en el público bilingüe en inglés y español y que fusiona la cultura con el idioma. La marca ha alcanzado un récord de 4,1 millones de usuarios en Comscore, lo cual supone un crecimiento interanual del 226% y sitúa a HOLA! USA como medio de entretenimiento hispano número 1 (non-network). Desde ahora, la marca lanzará portadas digitales mensuales de la edición En Español, y en el último trimestre de 2020, comenzará a publicar las portadas en la edición En Inglés. Ambas portadas serán bilingües para que tanto celebridades como lectores, se beneficien del legado intergeneracional y la cultura de HOLA!

Sobre HOLA! USA

HOLA! USA es parte del grupo ¡HOLA! y HELLO!, es una de las marcas editoriales con mayor presencia mundial, la cual fue fundada en 1944. Cuenta con 26 ediciones internacionales, 10 páginas web y presencia en 120 países. La misión de la marca es entretener desde historias sobre celebridades y casas reales hasta tendencias en moda, estilo de vida, cultura y belleza y eventos, incluyendo entrevistas exclusivas. HOLA! USA es el medio de entretenimiento hispano número 1 en Estados Unidos y, junto con su empresa hermana HELLO! US, está en el top 30 de publicaciones de lifestyle en Estados Unidos.

Follow HOLA! USA: Facebook: @revistaHOLAUSA – Instagram: @HolaUSA – Twitter: @usahola

Foto – https://mma.prnewswire.com/media/1223909/HOLA_USA_Nacho_Mendoza_Spanish.jpg

FUENTE HOLA! USA

InventHelp Inventor Creates Automotive Accessory (SUU-636)

PITTSBURGH, Aug. 4, 2020 /PRNewswire/ — «I had a flat and could not find anything to remove the center cap so you can take the tires off,» said an inventor from Foristell, Mo. «So, I created the CENTER CAP KEY.»

The patent-pending invention fulfills the need for removing the center caps from trucks with dual wheels. It saves time and effort when changing tires while also avoiding accidental damage to center caps. It would quickly and easily dislodge the center cap without risking costly damage. The user could also be spared painful muscle strains and possible hand injuries. When a flat tire is experienced, a motorist would not become stranded and unable to change the tire, thereby avoiding frustration and significant delays. This tool would be strong, reliable, cost effective, ergonomic, and practical. Additionally, the inventor’s prototype is available upon request.

The inventor described the unique features of their design. «My design allows you to take of the center cap, without breaking it.»

The original design was submitted to the St. Louis sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 19-SUU-636, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp’s Invention Submission Services at http://www.InventHelp.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/inventhelp-inventor-creates-automotive-accessory-suu-636-301103707.html

SOURCE InventHelp

Mount Sinai Researchers Discover Treatment Option for Rare Genetic Disorder

NEW YORK, Aug. 4, 2020 /PRNewswire-PRWeb/ — Researchers from the Icahn School of Medicine used a novel genetic sequencing technology to identify the genetic cause of—and a treatment for—a previously unknown severe auto inflam-matory syndrome affecting an 18-year-old girl since infancy.

The technology, tailored to the patient’s own genetic code at a single cell level, helped the re-searchers characterize an unknown mutation in a gene called JAK1 that caused the patient’s immune system to be permanently turned on, resulting in rashes over much of her skin, growth abnormalities, kidney failure, allergic hypersensitivities, and an unusual inflammatory condi-tion throughout the digestive tract.

The study, led by Dusan Bogunovic, PhD, Associate Professor of Microbiology, and Pediatrics, at the Icahn School of Medicine at Mount Sinai, faculty member of The Mindich Child Health and Development Institute and the Precision Immunology Institute at Mount Sinai, and Director of the Center for Inborn Errors of Immunity, was published in the August 3 issue of the journal Immunity. The discovery points toward new ways to study how genetic diseases manifest and presents a model of personalized diagnosis and treatment for patients with genetic diseases.

Autoinflammatory diseases are caused by abnormal activation of the immune system, leading to recurrent episodes of inflammation that may result in damaged or failed organs. The researchers determined that not all of the patient’s cells carried this mutation and had different genetic makeups or genotypes, what the researcher describe as a mosaic.

«Most genes use both their maternal and paternal copies, called alleles,» said Dr. Bogunovic. «Our findings show the JAK1 mutation in this patient used only one copy per cell, known as monoallelic expression. This challenges the textbook principles of genetics and may help ex-plain irregularities that are frequently encountered across genetic diseases.»

In the paper, the researchers describe the use of next-generation genomic, molecular, and multi-parametric immunological tools to probe the effects of the patient’s JAK1 mutation. By map-ping the genotype of JAK1 across the patient’s body, researchers were able to pinpoint precisely when the mutation arose in early development in the embryo. It later gave way to a host of symptoms from early childhood to early adulthood. The hunt began for a specific therapy that would curb the excessive activity of her mutant JAK1 and potentially cure her inflammatory symptoms.

«We identified one drug, tofacitinib, a JAK inhibitor, that curbed the excessive activity of her hyperactive inflammation. When administered the therapy, she rapidly improved within weeks. Her skin lesions cleared, her daily gastrointestinal symptoms resolved, and the clinical signs of inflammation went away, putting the patient in remission for two years until her unfortunate demise from coronavirus-related illness,» said Dr. Bogunovic. «This research helps better un-derstand the basic function of JAK1, which has broad implications for diseases of the immune system and how to treat them. In addition, the genetic discoveries uncovered in this case open up new research avenues into the complexities of how genetic diseases manifest and present a model of the future of personalized medicine. By coupling advanced clinical care with next-generation sequencing and detailed laboratory studies, we successfully diagnosed and treated a life-threatening disease.»

The research was accomplished with collaboration from the Vagelos College of Physicians and Surgeons at Columbia University Irving Medical Center, The Rockefeller University and New York University Grossman School of Medicine in New York City and the Universite de Nantes and Centre Hospitalier Universitaire de Nantes in Nantes, France.

About the Mount Sinai Health System
The Mount Sinai Health System is New York City’s largest academic medical system, encom-passing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most se-rious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s «Honor Roll» of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health Sys-tem hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twit-ter and YouTube.

SOURCE Mount Sinai Health System

Groundbreaking Research Reveals Black And Latinx Girls Are Left Out Of Leadership Pipeline From The Start Due To Systemic Racial Bias In Schools

OAKLAND, Calif., Aug. 4, 2020 /PRNewswire/ — GIRLS LEADERSHIP, a national, educational nonprofit started in 2009, announces new findings from READY TO LEAD, a groundbreaking research study that will monumentally impact the way that girls, especially Black and Latinx girls, are supported and taught to become skilled and ambitious leaders. These findings, released in partnership with lead sponsor Morgan Stanley, will inform new curriculum and pathways for leadership…

«We understand from the research findings that there is often a dangerous disconnect between the experiences and perspectives of our country’s teaching force—about 80% of whom are White women—and the girls—over 50% of whom are girls of color,» says Simone Marean, CEO and Cofounder of GIRLS LEADERSHIP. «This begged us to ask the question: What happens when Black and Latinx students, who know their power and already identify as leaders, speak up in a classroom? These findings forced us to think differently about how to properly support and train teachers to see the value—rather than the threat—of these strong voices. It also taught us that much more research is needed to understand this bias at the beginning, in elementary school.»

While attempting to better understand how and when girls develop their leadership identity and skills, GIRLS LEADERSHIP realized that existing studies were primarily focused on a very narrow scope of the population—White, middle class, and/or affluent girls. These studies did not account for important cultural distinctions for the majority of girls in the U.S.: girls of color.

«Morgan Stanley has a longstanding partnership with Girls Leadership and looks forward to working closely with them on the READY TO LEAD campaign, which will provide concrete actions to remove key barriers to leadership for young women of color,» says Susan Reid, Global Head of Diversity and Inclusion at Morgan Stanley. «Effecting positive and lasting change for marginalized communities is a central goal of our firm’s D&I efforts, and this campaign is a significant step in doing so for Black and Latinx women.»

GIRLS LEADERSHIP engaged Fluent Research to explore the internal and external factors that support and inhibit the leadership of girls of color. After surveying more than 2,000 girls and families and over 200 teachers nationally, and analyzing the qualitative and quantitative data, the organization determined the following:

Black & Latinx Girls Are Ready to Lead: Black and Latinx girls have the highest levels of self-reported confidence, identify as leaders, and have leadership aspirations.
Racial and Gender Bias Are the Key Barriers to Leadership: Black and Latinx girls identified the external factors of racial and gender bias present in their schools and broader society as significant obstacles to their leadership goals and opportunities.
Teacher Bias Limits Leadership Opportunities: Students of color experience bias and unfair treatment in the form of not having the same opportunity to get leadership roles, teachers have lower expectations for Black and Latinx students compared to White students, and Black and Latinx experience harsher disciplinary actions than White students who exhibit the same behaviors.
Teacher Support of Black and Latinx Girls’ Leadership Is Important: Black and Latinx girls score higher on the leadership scale than girls of other races/ethnicities, even if they are in schools with predominantly White teachers. However, in schools with predominantly teachers of color, Black and Latinx girls score even higher on the leadership scale.
Parents and Mentors Contribute Significantly to Positive Leadership Aspirations: Black and Latinx girls who have parents and mentors who think of and refer to them as leaders positively correlates with higher scores on the leadership scale as well as the earning of higher grades.

These findings quantify both the strengths and assets of Black and Latinx girls and proves that they are poised to step into leadership—at school and beyond. Yet, institutional racial and gender bias in educational organizations and the broader society prevent Black and Latinx girls from fully activating their potential.

GIRLS LEADERSHIP seeks to shed light on these disparities and their unfortunate impact on Black and Latinx girls in order to be a conduit of change for how we design girls’ leadership curriculum and teach them in the U.S.. Through its proprietary Power ColLABorative Training—a professional development for teachers and youth-serving professionals focused on culturally responsive, girl-centered leadership development—GIRLS LEADERSHIP aims to build on its programs and scale its reach based on these findings.

GIRLS LEADERSHIP—with the support of Morgan Stanley in its role as lead sponsor of the READY TO LEAD study—is helping to permeate policy, culture, and practices in order to tell a new story about what happens to the power of the voices and leadership aspirations of girls of color in adolescence.

To support the research study, GIRLS LEADERSHIP is launching a social media campaign that focuses on encouraging Black and Latinx women and girls to share their personal stories about embracing their leadership abilities and finding their voice via the #ReadyToLead social media hashtag. The campaign will create a groundswell of community sharing while demanding necessary policy and systemic change to rebuild schools as the foundation of leadership, influence, and power for all girls.

To learn more, visit readytolead.girlsleadership.org and join the conversation with #ReadyToLead.

Other sponsors of this study include Genentech, Vodafone, Applied Materials Foundation, New York Women’s Foundation, Billie Jean King Leadership Foundation, The Harnisch Foundation, Paul Weiss, and Airbnb.

ABOUT GIRLS LEADERSHIP: Founded in 2009, Girls Leadership is a national educational nonprofit fiercely committed to teaching girls K–12 to exercise the power of their voice. GIRLS LEADERSHIP is devoted to understanding the personal, cultural, and structural factors that impact girls’ leadership identity and skill development at a crucial point in their trajectory. Its goal is to raise the bar on how institutions approach fostering leadership development for girls in a way that truly incorporates and addresses the impact of trauma, important cultural differences, and racial bias.

Media Contact:
Jennifer Arranaga
Jennifer@invisiblehand.c o
949-375-5043

View original content:http://www.prnewswire.com/news-releases/groundbreaking-research-reveals-black-and-latinx-girls-are-left-out-of-leadership-pipeline-from-the-start-due-to-systemic-racial-bias-in-schools-301105891.html

SOURCE Girls Leadership

The Point-of-Care Ultrasound Certification Academy announces Doctors Without Borders as MissionPOCUS selection for 2020

ROCKVILLE, Maryland, Aug. 4, 2020 /PRNewswire/ — The Point-of-Care Ultrasound Certification Academy™ is announcing Médecins Sans Frontières (MSF), also known as Doctors Without Borders, as the selection of their MissionPOCUS™ project for the 2020 fiscal year. As the third MissionPOCUS project since the initiative’s inception in 2018, Inteleos’ MissionPOCUS will award MSF a grant that will establish a pilot program between the two organizations to evaluate the possibility of integrating POCUS certification into MSF’s POCUS education and training processes. The pilot is focused on developing a unique POCUS certification that will translate across resource-limited areas, with the goal of expanding the proficient use of point-of-care ultrasound to clinicians around the globe. For the POCUS Certification Academy, the project is slated to lay the foundation for greater conversation and action toward the use of POCUS in rural areas, specifically in developing nations.

For more information about MissionPOCUS or the MSF Pilot, please visit pocus.org/missionpocus/. For more information about the Point-of-Care Ultrasound Certification Academy, please visit www.POCUS.org. For more information on Médecins Sans Frontières (Doctors Without Borders), please visit msf.org.

Inteleos™ is a non-profit certification organization that delivers rigorous assessments and cultivates a global community of professionals dedicated to the highest standards in healthcare and patient safety. Inteleos is the overarching governance and management organization for the American Registry for Diagnostic Medical Sonography® (ARDMS®) the Alliance for Physician Certification and Advancement™ (APCA™) and the Point-of-Care Ultrasound Certification Academy™ which represents over 116,000 certified medical professionals throughout the world.

The Point-of-Care Ultrasound Certification Academy™ administers examinations and awards certificates in the areas of Point-of-Care Ultrasound (POCUS). The POCUS Certification Academy exists to provide physicians and advanced-practice practitioners the opportunity to collaborate in the shared mission of improving global health and setting the standards of excellence in POCUS.

Médecins Sans Frontières (MSF) translates to Doctors without Borders. They provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Their teams are made up of tens of thousands of health professionals, logistic and administrative staff – bound together by a charter. Their actions are guided by medical ethics and the principles of impartiality, independence, and neutrality. They are a non-profit, self-governed, member-based organization. MSF was founded in 1971 in Paris by a group of journalists and doctors. Today, they are a worldwide movement of more than 67,000 people.

For inquiries about the POCUS Certification Academy, contact: POCUS@Inteleos.org

Photo – https://mma.prnewswire.com/media/1223819/Inteleos_Mission_Pocus_MSF.jpg

FONTE Inteleos

Infosys USA Certified as Great Place to Work®

RICHARDSON, Texas, Aug. 4, 2020 /PRNewswire/ — Infosys (NYSE: INFY), a global leader in next-generation digital services and consulting, has been certified as a Great Place to Work^® in the United States. This award recognizes best in class workplaces and company cultures based upon employee responses to the Great Place to Work^® Trust Index^™ Survey….

Ravi Kumar S, President, Infosys, said, «This recognition is a testament to Infosys’ strategic commitment to hiring and fostering employee development in North America. At Infosys we are driving American innovation and helping shrink the IT skills gap through investment in training and education for both employees and through our university partners.»

Since 2017, Infosys has hired over 13,000 employees and opened six digital and innovation centers in Indianapolis, Indiana, Hartford, Connecticut; Phoenix, Arizona; Providence, Rhode Island; Raleigh, North Carolina; and Richardson, Texas.

In keeping with Infosys’ commitment to workforce development and in light of the economic and employment challenges created by the COVID-19 pandemic, Infosys recently announced Reskill and Restart, a program created in partnership with leading skills assessment and training companies that will leverage Infosys’ Wingspan to meet the reskilling and employment needs of American workers adversely affected by the pandemic. Internally, Infosys continues to help create the next generation of talent through its highly regarded InStep internship program and university partnerships with the likes of Cornell University, Rhode Island School of Design, The University of Arizona, Purdue, NC State and Trinity College.

Sarah Lewis-Kulin, Vice President, Best Workplace List Research, Great Place to Work, said, «We congratulate Infosys on their Certification. Organizations that earn their employees’ trust create great workplace cultures that deliver outstanding business results.»

This is the first time that Infosys, USA has pursued an external certification. The certification confirms that 7 out of 10 employees have a consistently positive experience at Infosys.

About Great Place to Work®

Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees around the world and used those deep insights to define what makes a great workplace: trust. Great Place to Work helps organizations quantify their culture and produce better business results by creating a high-trust work experience for all employees. Their unparalleled benchmark data is used to recognize Great Place to Work-Certified™ companies and the Best Workplaces™ in the U.S. and more than 60 countries, including the 100 Best Companies to Work For® and World’s Best list published annually in Fortune.

To learn more, visit Great Place to Work® online at www.greatplacetowork.com.

About Infosys Ltd.

Infosys is a global leader in next-generation digital services and consulting. We enable clients in 46 countries to navigate their digital transformation. With nearly four decades of experience in managing the systems and workings of global enterprises, we expertly steer our clients through their digital journey. We do it by enabling the enterprise with an AI-powered core that helps prioritize the execution of change. We also empower the business with agile digital at scale to deliver unprecedented levels of performance and customer delight. Our always-on learning agenda drives their continuous improvement through building and transferring digital skills, expertise, and ideas from our innovation ecosystem.

Visit www.infosys.com to see how Infosys (NYSE: INFY) can help your enterprise navigate your next.

Infosys Safe Harbor Statement

Certain statements in this release concerning Infosys’s future growth prospects, financial expectations and plans for navigating the COVID-19 impact on Infosys employees, clients and stakeholders are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding COVID-19 and the effects of government and other measures seeking to contain its spread, risks related to an economic downturn or recession in India, the United States and other countries around the world, changes in political, business, and economic conditions, fluctuations in earnings, fluctuations in foreign exchange rates, Infosys’s ability to manage growth, intense competition in IT services including those factors which may affect cost advantage, wage increases in India, the ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, Infosys’s ability to manage international operations, reduced demand for technology in key focus areas, disruptions in telecommunication networks or system failures, the ability to successfully complete and integrate potential acquisitions, liability for damages in service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, unauthorized use of Infosys intellectual property and general economic conditions affecting the industry and the outcome of pending litigation and government investigation. Additional risks that could affect our future operating results are more fully described in Infosys’s United States Securities and Exchange Commission filings including Infosys’s Annual Report on Form 20-F for the fiscal year ended March 31, 2020. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in Infosys company filings with the Securities and Exchange Commission and reports to shareholders. Infosys does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company unless it is required by law.

All asset figures as of May 31, 2020, unless otherwise noted.

Advice services are provided by Vanguard Advisers, Inc., a registered investment advisor, or by Vanguard National Trust Company, a federally chartered, limited-purpose trust company.

All investing is subject to risk, including the possible loss of the money you invest.

For more information, please contact PR_Global@Infosys.com

View original content:http://www.prnewswire.com/news-releases/infosys-usa-certified-as-great-place-to-work-301105883.html

SOURCE Infosys

OPB transforms its digital news offering with launch of new website

PORTLAND, Ore., Aug. 4, 2020 /PRNewswire/ — Oregon Public Broadcasting (OPB), a member-supported public media organization serving the Northwest, today announced the launch of its

PORTLAND, Ore., Aug. 4, 2020 /PRNewswire/ — Oregon Public Broadcasting (OPB), a member-supported public media organization serving the Northwest, today announced the launch of its new website, offering people across the region a more accessible, enhanced OPB digital experience.

Furthering its commitment to delivering critical, independent journalism and essential storytelling to all communities in the Northwest, OPB’s new website at opb.org was designed and built with the digital needs and content consumption habits of OPB’s audience at the forefront. The website employs a journalistic, story-first approach, which showcases OPB’s in-depth news, politics, arts, culture, science and environment reporting that is curated and easy to navigate.

The site is powered by Arc Publishing, an award-winning, state-of-the-art digital platform built by The Washington Post. OPB is the first public media organization in the country to use the Arc solution. OPB selected Arc because of its robust infrastructure, fast speed and innovative editorial tools — allowing OPB journalists to quickly and effectively deliver important news and information to its wide audience.

«Our redesigned website supports OPB’s growing role as a significant news source for audiences in Oregon and Washington,» said Morgan Holm, chief content officer at OPB. «With Arc, we can deliver a rich multimedia storytelling experience to our digital audience, showcasing the exceptional work that OPB’s team produces each day. This site improves our ability to carry out our public service journalism mission.»

For users, the site offers a simpler, more intuitive navigation process for OPB stories, faster page loading, ease of search and is built with increased accessibility in mind. It is designed to meet Web Content Accessibility Guidelines (WCAG) for color contrast, font size and labeling of elements for those using a screen reader.

In addition to these technical capabilities, OPB’s new site offers a more immersive digital storytelling experience — incorporating a variety of multimedia elements into each story such as award-winning video, audio, graphics and photos. From breaking news reporting to magazine-style features and deep investigative series, the site’s cohesive presentation makes it easy for users to gain the essential context behind the important stories unfolding in their own backyards.

For those who enjoy listening to live audio streaming of OPB Radio, opbmusic and KMHD Jazz Radio, the new site features a powerful new streaming platform powered by Empire Streaming. Users can also easily find favorite podcasts, OPB original series, broadcast schedules and more.

As OPB is a member-supported media organization, the site also makes joining OPB and managing an OPB membership a more seamless experience. Users can easily access all of the ways to stay connected to everything OPB has to offer, including subscribing to the suite of OPB newsletters, mobile alerts and more.

About OPB
OPB is a nationally recognized leader in public media, providing news, information and entertainment to the Northwest. With award-winning journalists and original series, OPB illuminates the people, places and issues of the region and puts stories into context. OPB creates content and programming that can be accessed anywhere, at any time on OPB TV, OPB Radio, opb.org and on a variety of digital and social media platforms. For more information, visit www.opb.org.

View original content to download multimedia:http://www.prnewswire.com/news-releases/opb-transforms-its-digital-news-offering-with-launch-of-new-website-301105871.html

SOURCE Oregon Public Broadcasting

PeopleStrategy, Lighthouse Research & NAAAHR-Atlanta to Hold Anti-Racism Forum

EDISON, N.J., Aug. 4, 2020 /PRNewswire/ — The senseless deaths of George Floyd, Ahmaud Arbery, Breonna Taylor and countless others have served as a vivid reminder that the reality for Black Americans has remained largely unchanged since the beginning of our country’s history, despite past efforts. We also have been reminded of the vast inequities and deep-rooted biases that continue to marginalize people…

It is time for change. It is time for unity. It is time for justice. It is time for true equality. It is time to do the work.

PeopleStrategy is committed to doing the work to help bring about change that will help to end social and racial injustice and inequality, and here is how we intend to demonstrate our commitment.

We Will Support Our Communities

We have started to build an external strategy to demonstrate our commitment and support for the communities we serve. As a benefits broker and HR technology provider, employers and, more specifically, HR and benefits professionals, are the biggest community we serve.

Recognizing that HR and business leaders may be struggling to know where to begin when it comes to building an actively anti-racist workplace, PeopleStrategy is planning a live virtual event, «Going Beyond Diversity & Inclusion: an Open Forum on Anti-Racism.» The goal of this event is to provide a forum that facilitates open, honest and uncomfortable conversations. We believe that is a critical first step toward real and meaningful change.

To help maximize our reach and provide the most valuable experience possible, PeopleStrategy has joined forces with the Atlanta chapter of the National Association of African Americans in Human Resources and Ben Eubanks, principal analyst at Lighthouse Research & Advisory. Daily sessions will feature panelists who can provide real-life experience, expert guidance and thought-provoking dialogue on race, systemic racism, social injustice, unconscious bias, microaggressions, hiring practices, and much more.

For more information or to register, visit: https://www.peoplestrategy.com/AntiracismForum

This will be the launching pad for similar events and activities to help sustain the momentum we currently see throughout our country.

We Will Support Our PeopleStrategy Family

We are executing an internal strategy to facilitate awareness, communication and education (FACE) among the PeopleStrategy family about the issues confronting our nation today. Known as FACE, this team is evaluating a variety of methods by which we can become a workplace where every employee feels equally respected, valued and supported.

We Will Honor Our Commitment

PeopleStrategy reaffirms our commitment to conduct business in a way that reflects not only Integrity but also: Equality & Justice, Diversity & Inclusion, Solidarity & Unity and Empathy & Compassion.

Contact Information
Lesley Lyons, Director of Marketing
Phone: 678-793-3279
Email: Lesley.Lyons@peoplestrategy.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/peoplestrategy-lighthouse-research–naaahr-atlanta-to-hold-anti-racism-forum-301105886.html

SOURCE PeopleStrategy, Inc.

Stellar Pulsations Distribute Key Ingredient for Life

COLUMBIA, Md., Aug. 4, 2020 /PRNewswire/ — As Carl Sagan famously said, «We’re made of star stuff» — but how do stars distribute their essential «stuff» for life into space? NASA’s telescope on an airplane, SOFIA, is finding some answers by watching pulsating stars as they expand and contract, almost like beating hearts.

The Stratospheric Observatory for Infrared Astronomy, SOFIA, examined several types of pulsating stars in our Milky Way galaxy, watching…

The Stratospheric Observatory for Infrared Astronomy, SOFIA, examined several types of pulsating stars in our Milky Way galaxy, watching as some spewed carbon, into interstellar space.Carbon is created deep inside stars through the process of helium fusion. As stars evolve, this carbon can get dredged up to the surface. But it must be forced into space for it to become a building block of life as we know it.

SOFIA found that some Mira stars, late-stage red giants with especially powerful pulsations, can drive strong stellar winds that eject carbon-rich gas and dust out into interstellar space. On the other hand, stars with much weaker pulsations called semiregular stars, can’t push the wind out as effectively. The Mira Stars are therefore responsible for distributing large amounts of carbon into the universe. The research was published in The Astrophysical Journal.

«We know that essential chemicals like carbon come from stars,» said Kathleen Kraemer, a scientist at Boston College and lead author of the study. «But these strong pulsations help explain how carbon moves away from stars to where it can evolve into more complex structures, which in the case of Earth, ultimately became DNA — life.»

Previous research observed pulsating stars in other galaxies, like the Large Magellanic Cloud, but this research with SOFIA provides new insights into how carbon gets distributed in our own Milky Way galaxy.

For more information see: https://iopscience.iop.org/article/10.3847/1538-4357/ab4f6b

ABOUT SOFIA

SOFIA, the Stratospheric Observatory for Infrared Astronomy, is a Boeing 747SP jetliner modified to carry a 106-inch diameter telescope. It is a joint project of NASA and the German Aerospace Center, DLR. NASA’s Ames Research Center in California’s Silicon Valley manages the SOFIA program, science and mission operations in cooperation with the Universities Space Research Association headquartered in Columbia, Maryland, and the German SOFIA Institute (DSI) at the University of Stuttgart. The aircraft is maintained and operated from NASA’s Armstrong Flight Research Center Building 703, in Palmdale, California.

PR Contact:
Suraiya Farukhi, Ph.D.
sfarukhi@usra.edu
410-740-6224; 443-812-6945

View original content to download multimedia:http://www.prnewswire.com/news-releases/stellar-pulsations-distribute-key-ingredient-for-life-301105865.html

SOURCE Universities Space Research Association